Kobayashi K, Kanda H, Shimazaki R, Murata T, Kobayashi M. Economic Evaluation of Egfr Control In Patients With Chronic Kidney Disease In Japan. ISPOR 20th Annual European Congress Glasgow, Scotland. Research Poster Presentations. Nov 6, 2017.
Noto S, Igarashi A, Shiroiwa T, Fukuda T, Ikeda S, Moriwaki K, Saito S, Shimozuma K, Ishida H, Kobayashi M. Reliability And Validity Of Two Proxy Versions Of EQ-5D-5L In Japan. ISPOR 20th Annual European Congress Glasgow, Scotland. Research Poster Presentations. Nov 7, 2017.
Noto S, Izumi R, Moriwaki K, Shiroiwa T, Igarashi A, Fukuda T, Ikeda S, Saito S, Shimozuma K, Ishida H, Kobayashi M. Comparison Between Eq-5d And Hui In Japanese Population Norms. ISPOR 20th Annual European Congress Glasgow, Scotland. Nov 4-8, 2017.
Yamabe K, Inoue S, Kuwabara H, Kobayashi M. Cost-Effectiveness Analysis For Treatment Of Parkinson’s Disease: A Systematic Review. ISPOR 20th Annual European Congress Glasgow, Scotland. Nov 4-8, 2017.
Noto S, Sengoku A, Nomi M, Murata T, Kato S. Relationship between bowel dysfunction and health-related QOL in patients with spinal cord injury. The 51st Japanese Cvvupational Therapy Congress & Expo. 22-24 September, 2017.
Seno A, Yin C, Metz L, Ghosh SK, Murata T, Kobayashi M. The treatment effect on early stage hepatocellular carcinoma in Japanese population: Literature review. ISPOR 22nd Annual International Meeting Boston USA. Research Poster Presentations. May 22, 2017.
Okumura H, Inoue S, Naidoo S, Holmstrom S, Akaza H. Cost-effectiveness analysis of enzalutamide for patients with pre-metastatic castration-resistant prostate cancer. The 105th Annual Meeting of the Japanese Urological Association. April 21-24, 2017.
Nitta K, Sugiyama K, Wajima R, Tachibana M, Inoue S, Daitou T, Kurashima H. Study on the forecas of risk of suffering severe vision disability with primary open angle Glaucoma(broadly defined). The 121st Annual Meeting of the Japanese Ophthalmological Sciety. April 6-9, 2017.
Wang F, Murata T, Izumi N, Kida M, Horblyuk R, Terayama Y. Bleeding risk among Japanese non-valvular atrial fibrillation patients initiated on Apixaban, Dabigatran, Rivaroxaban or Warfarin in the real world. American College of Cardiology. March 18, 2017.
Kobayashi M. The trial intordoction of cost-effectiveness evoluation and future prospects in japan. 4th seminar of the center of pharmacoeconomics and QOL research at Niigata University of health and welfare. Niigata University of health and welfare, Niigata, Japan. 4th Mar, 2017. (in Japanese).